Evaxion A (EVAX) EBT (2020 - 2026)
Evaxion A's (EVAX) quarterly EBT came in at -$3.8 million in Q1 2026, down 116.99% YoY from $22.6 million in Q1 2025, and up 37.72% on a QoQ basis from -$6.2 million in Q4 2025.
Evaxion A (EVAX) EBT (2020 - 2026) Analysis & Trends
Evaxion A (EVAX) has 7 years of EBT data on file, last reported at -$3.8 million in Q1 2026.
- Quarterly EBT fell 116.99% year-over-year to -$3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.7 million (up 23.1% YoY) and the FY2025 annual result came in at -$8.6 million, up 24.13% from the prior year.
- EBT climbed to -$3.8 million in Q1 2026, from -$6.2 million in the prior quarter.
- In the past five years, EBT ranged from a high of $4.4 million in Q3 2025 to a low of -$7.0 million in Q4 2022.
- A 5-year average of -$3.6 million and a median of -$4.7 million in 2023 frame the typical range for EBT.
- Annual changes were most pronounced in 2023 — EBT tumbled 968.94% — and 2025, when it surged 314.28%.
- Tracing EVAX's EBT over 5 years: stood at -$7.0 million in 2022, then jumped by 33.29% to -$4.7 million in 2023, then advanced by 16.94% to -$3.9 million in 2024, then plunged by 58.15% to -$6.2 million in 2025, then soared by 37.72% to -$3.8 million in 2026.
- The last three EBT figures came in at -$3.8 million (Q1 2026), -$6.2 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Evaxion A | 26.86 Mn | 26.86 Mn | - | -3.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.85 Mn |
| Dec 31, 2025 | -6.17 Mn |
| Sep 30, 2025 | 4.35 Mn |
| Jun 30, 2025 | -5.03 Mn |
| Mar 31, 2025 | -1.77 Mn |
| Dec 31, 2024 | -3.90 Mn |
| Sep 30, 2024 | -2.03 Mn |
| Jun 30, 2024 | -6.20 Mn |
| Mar 31, 2024 | 976,000.00 |
| Dec 31, 2023 | -4.70 Mn |
| Sep 30, 2023 | -5.87 Mn |
| Jun 30, 2023 | -5.91 Mn |
| Mar 31, 2023 | -6.44 Mn |
| Dec 31, 2022 | -7.05 Mn |
| Sep 30, 2022 | -5.92 Mn |
| Jun 30, 2022 | -1.60 Mn |
| Mar 31, 2022 | -602,000.00 |
| Dec 31, 2021 | -7.05 Mn |
| Sep 30, 2021 | -17.66 Mn |
| Jun 30, 2021 | 423,000.00 |